autoimmune diseases

Showing NaN - NaN of 12

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stroke, Subarachnoid Hemorrhage, Traumatic Brain Injury Trial in London (Music Therapy, Control Therapy)

Not yet recruiting
  • Stroke
  • +8 more
  • Music Therapy
  • Control Therapy
  • London, United Kingdom
    University College Hospitals NHS Foundation Trust
Mar 8, 2023

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in London (Dexcom G6, Self monitoring of blood glucose)

Recruiting
  • Diabetes Mellitus
  • +5 more
  • Dexcom G6
  • Self monitoring of blood glucose
  • London, United Kingdom
    Imperial College Clinical Research Facility
Jun 23, 2022

Lateral Flow Immunoassays for Detection of SARS-CoV-2 Antibodies

Recruiting
  • Solid Organ Transplant Recipients
  • +2 more
  • self-administered lateral flow assays
  • Bristol, United Kingdom
  • +3 more
May 25, 2022

Prospective Study of White Blood Cells

Recruiting
  • Autoimmune Diseases
  • +2 more
  • White blood cell and blood collection
  • London, United Kingdom
    Quell Investigator Site 01
Apr 6, 2021

Neurological Disorder, Autoimmune Diseases Trial in Canada, United States (Mycophenolate Mofetil, Azathioprine)

Completed
  • Neurological Disorder
  • Autoimmune Diseases
  • Palo Alto, California
  • +18 more
Feb 2, 2021

Autoimmune Diseases, Relapsing Multiple Sclerosis Trial in London (Fecal microbiota)

Terminated
  • Autoimmune Diseases
  • Relapsing Multiple Sclerosis
  • Fecal microbiota
  • London, Ontario, Canada
    London Health Sciences Centre, University Hospital
Nov 12, 2019

Autoimmune Diseases Trial in Cambridge, London (18F-FDG PET/CT Imaging, 11C-MET PET/CT Imaging, MRI Imaging with intravenous

Completed
  • Autoimmune Diseases
  • 18F-FDG PET/CT Imaging
  • +3 more
  • Cambridge, United Kingdom
  • +3 more
Oct 23, 2019

Autoimmune Diseases Trial in London (Azithromycin - 250 mg, Azithromycin - 1000 mg, Azithromycin - 250 mg every other day for 3

Completed
  • Autoimmune Diseases
  • Azithromycin - 250 mg
  • +2 more
  • London, United Kingdom
    GSK Investigational Site
Jul 18, 2017

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Cambridge, Leeds, London (Overnight closed-loop, Real-time CGM

Completed
  • Diabetes Mellitus
  • +4 more
  • Overnight closed-loop
  • Real-time CGM alone
  • Cambridge, United Kingdom
  • +2 more
Feb 28, 2017

Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases Trial in Worldwide (Golimumab 50 mg SC, Golimumab 2 mg/kg IV, Methotrexate

Completed
  • Arthritis
  • +2 more
  • Golimumab 50 mg SC
  • +4 more
  • Birmingham, Alabama
  • +116 more
Apr 9, 2015

Raynaud's Disease, Scleroderma, Autoimmune Diseases Trial in Sweden, United Kingdom, United States (Topical AmphiMatrix with

Completed
  • Raynaud's Disease
  • +2 more
  • Topical AmphiMatrix with nitroglycerin (MQX-503)
  • Stanford, California
  • +11 more
May 29, 2007

Immunologic Diseases, Autoimmune Diseases, Systemic Lupus Erythematosus Trial in Worldwide (Abetimus sodium (LJP 394))

Completed
  • Immunologic Diseases
  • +4 more
  • Abetimus sodium (LJP 394)
  • Birmingham, Alabama
  • +81 more
Sep 22, 2006